Toxoplasmosis in Cats: Zoonotic Risks and Management During Pregnancy
Introduction
Toxoplasmosis is a globally distributed parasitic zoonosis caused by the obligate intracellular protozoan Toxoplasma gondii. The domestic cat (Felis catus) serves as the definitive host for this parasite, a role that places it at the center of zoonotic transmission cycles [1, 2]. Understanding the biological mechanisms of T. gondii infection in cats, the pathways of transmission to humans, and the specific risks during pregnancy is essential for veterinary practitioners and public health professionals. This article provides a detailed, evidence-based review of the life cycle, epidemiology, clinical presentation, diagnostic approaches, therapeutic options, and prevention strategies for toxoplasmosis in cats, with a focused discussion on the zoonotic risks to pregnant women and the management of the cat toxoplasmosis baby transmission pathway.
Life Cycle and Biology of Toxoplasma gondii
Toxoplasma gondii exhibits a complex, heteroxenous life cycle that involves both definitive and intermediate hosts. Felids, including domestic cats, are the only definitive hosts in which the parasite can complete its sexual cycle and produce oocysts [1, 2]. The life cycle proceeds through three main infectious stages: tachyzoites, bradyzoites (contained within tissue cysts), and sporozoites (contained within sporulated oocysts).
Cats become infected primarily through the ingestion of tissue cysts containing bradyzoites in the skeletal muscle or organs of intermediate hosts such as rodents and birds [1, 2]. After ingestion, the cyst wall is digested by proteolytic enzymes in the stomach and small intestine, releasing bradyzoites that invade the epithelial cells of the feline small intestine. Within these enterocytes, the parasite undergoes multiple rounds of asexual replication (schizogony) followed by sexual differentiation into gametocytes. Fertilization occurs within the intestinal lumen, leading to the formation of unsporulated oocysts that are shed in the feces [1, 2].
The prepatent period, defined as the time between infection and the onset of oocyst shedding, is typically 3 to 10 days after ingestion of bradyzoites but can be longer (up to 21 days) after ingestion of oocysts or tachyzoites [2]. A cat may shed millions of oocysts per day for 1 to 3 weeks. Once shed, oocysts require 1 to 5 days of exposure to oxygen and appropriate temperature and humidity conditions to sporulate and become infectious [1, 2]. Sporulated oocysts are remarkably resilient, surviving for months to years in moist soil, sand, and water.
Intermediate hosts, including humans and a wide range of warm-blooded animals, acquire infection through ingestion of sporulated oocysts from contaminated environments or through ingestion of tissue cysts in undercooked meat [2]. In intermediate hosts, the parasite disseminates as rapidly dividing tachyzoites during the acute phase, then differentiates into slowly dividing bradyzoites that form tissue cysts, predominantly in neural and muscular tissues [2].
Epidemiology in Cats
Seroprevalence of T. gondii in domestic cat populations varies widely depending on geographic location, age, lifestyle, and hunting behavior. Seroprevalence rates in cats range from less than 10% in some indoor-only populations to over 60% in free-roaming or feral cat colonies [1, 2]. The primary risk factors for seropositivity in cats include outdoor access, raw or undercooked meat consumption, and rodent hunting activity [2].
Oocyst shedding is typically a transient event in the life of a cat, occurring primarily after primary infection. Re-shedding can occur upon reinfection or during periods of immunosuppression, but it is generally less intense and of shorter duration than primary shedding [2]. The vast majority of cats that have seroconverted are no longer actively shedding oocysts, which has important implications for risk assessment in households with pregnant women.
Clinical Signs in Cats
Most immunocompetent cats infected with T. gondii remain asymptomatic [2]. When clinical disease does occur, it is most commonly observed in kittens, immunocompromised cats, or cats co-infected with other pathogens. Clinical toxoplasmosis in cats can manifest in several forms.
Feline Toxoplasmosis: Clinical Manifestations
The most frequently reported clinical syndrome is systemic toxoplasmosis, which often presents with nonspecific signs including fever, lethargy, anorexia, and weight loss [2]. Pulmonary involvement can lead to tachypnea, dyspnea, and coughing. Hepatic involvement may result in icterus and elevated liver enzyme activities.
Ocular toxoplasmosis is a common manifestation in cats, presenting as uveitis, chorioretinitis, or anterior chamber inflammation [2]. The classic ocular lesion is a focal or multifocal chorioretinitis, often described as a "headlight in the fog" appearance on fundic examination.
Neurological toxoplasmosis results from the formation of tissue cysts and associated inflammation in the central nervous system. Clinical signs can include ataxia, circling, head tilt, seizures, tremors, and behavioral changes [2]. The neurological form is more common in immunocompromised cats, including those infected with feline immunodeficiency virus or feline leukemia virus.
Zoonotic Transmission and the Cat Toxoplasmosis Baby Pathway
The zoonotic transmission of T. gondii from cats to humans occurs primarily through the accidental ingestion of sporulated oocysts. This is the central concern in the cat toxoplasmosis baby transmission pathway, where a pregnant woman may acquire a primary infection that leads to congenital transmission to the fetus [1, 3, 4, 5, 6, 2, 7].
Routes of Human Infection
Humans can acquire T. gondii infection through three principal routes:
- Ingestion of sporulated oocysts from contaminated soil, water, or food. This is the primary route associated with feline fecal contamination [1, 2].
- Ingestion of tissue cysts in undercooked or raw meat, particularly pork, lamb, and game meat [2].
- Vertical transmission from an infected mother to her fetus during pregnancy [1, 5, 6, 2, 7].
Direct handling of cats is not considered a major risk factor for human infection, as cats typically do not carry infectious oocysts on their fur or in their saliva [4, 2]. The risk arises from contact with cat feces, specifically from litter boxes, garden soil, or sandboxes contaminated with sporulated oocysts [4, 2].
Risks During Pregnancy
Primary infection with T. gondii during pregnancy poses a significant risk of congenital toxoplasmosis. The risk and severity of fetal infection depend on the gestational stage at which maternal infection occurs [1, 5, 6, 2, 7].
If a woman acquires a primary T. gondii infection shortly before or during pregnancy, the parasite can cross the placental barrier and infect the developing fetus [1, 2]. The risk of vertical transmission increases with advancing gestational age. Infection in the first trimester carries a lower transmission risk (approximately 10% to 15%) but is associated with more severe fetal outcomes, including miscarriage, stillbirth, or severe neurological and ocular damage [1, 5, 2]. Infection in the third trimester carries a higher transmission risk (up to 60% to 80%) but is more likely to result in subclinical infection at birth, with potential for late-onset sequelae such as chorioretinitis and developmental delays [5, 2].
Congenital toxoplasmosis can manifest as a classic triad of chorioretinitis, hydrocephalus, and intracranial calcifications, although many infected infants are asymptomatic at birth [5, 2]. Long-term complications can include visual impairment, hearing loss, and neurocognitive deficits [5, 2].
Several studies have investigated the seroprevalence of T. gondii antibodies in pregnant women and associated risk factors. Seroprevalence rates vary widely by region. In a study conducted in rural Burkina Faso, seroprevalence among pregnant women attending their first antenatal care visit was reported at 38.5% [6]. In Biskra, Southeastern Algeria, a cross-sectional survey found a seroprevalence of 32.7% among pregnant women, with significant associations identified for contact with soil and consumption of raw vegetables [7]. A study in Abidjan, Cote d'Ivoire, highlighted that knowledge and practices regarding toxoplasmosis prevention among pregnant women were suboptimal, indicating a need for improved health education [3]. In Kars, Turkey, investigation of women with a history of abortion or stillbirth revealed a seropositivity rate of 42.3%, with cat ownership identified as a significant risk factor [1]. A review of prevalence, risk factors, diagnosis, and outcomes of T. gondii infection in pregnancy confirmed that seronegative women who own cats or engage in gardening are at elevated risk for primary infection [2]. The burden of congenital toxoplasmosis was assessed in Burundi, where the incidence was estimated at 1.5 cases per 1,000 live births, underscoring the public health importance of this condition in resource-limited settings [5].
Diagnostic Methods
Accurate diagnosis of T. gondii infection in cats and in pregnant women is critical for appropriate management. Diagnostic approaches include serological, molecular, and histopathological methods.
Serology
Serological detection of anti-T. gondii antibodies is the most commonly used diagnostic approach in both cats and humans. In cats, detection of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies can indicate recent or past infection [2]. A positive IgM result suggests recent infection or reactivation, while a positive IgG result indicates prior exposure and immunity. In pregnant women, serological screening is used to determine serostatus. Women who are seronegative are considered susceptible to primary infection and are advised to follow strict preventive measures [3, 4, 6, 2, 7]. Seroconversion from negative to positive during pregnancy is diagnostic of primary infection [2].
Commercial enzyme-linked immunosorbent assay (ELISA) kits and indirect immunofluorescence assays are widely used for serological testing [2]. The sensitivity and specificity of these assays vary, and confirmatory testing with a reference method such as the Sabin-Feldman dye test may be required in equivocal cases.
Molecular Diagnostics
Polymerase chain reaction (PCR) assays targeting the T. gondii B1 gene or the 529 base pair repeat element are highly sensitive and specific for detecting parasite DNA in clinical samples [2]. In cats, PCR can be performed on feces to detect oocyst shedding, although this is rarely done in clinical practice due to the transient nature of shedding. In pregnant women and fetuses, PCR can be performed on amniotic fluid, fetal blood, or placental tissue to confirm congenital infection [2]. Real-time PCR allows for quantification of parasite load, which may correlate with disease severity.
Histopathology and Cytology
Histopathological examination of tissues can reveal tachyzoites or tissue cysts in association with inflammatory lesions. Immunohistochemical staining using anti-T. gondii antibodies enhances detection sensitivity [2]. Cytological examination of cerebrospinal fluid, bronchoalveolar lavage fluid, or aqueous humor may also reveal tachyzoites in clinically affected cats.
Treatment Options
Treatment of toxoplasmosis in cats is indicated when clinical disease is present. The goal of therapy is to reduce the parasite burden and control inflammation.
Antiprotozoal Therapy
The standard treatment regimen for clinical feline toxoplasmosis involves a combination of clindamycin and a sulfonamide antibiotic, typically sulfadiazine or sulfamethoxazole, often administered in conjunction with trimethoprim [2]. Clindamycin is administered at a dosage of 10 to 12 mg/kg orally or intramuscularly every 12 hours for 2 to 4 weeks. The sulfonamide-trimethoprim combination is given at 15 mg/kg orally every 12 hours. These drugs inhibit folate synthesis and protein synthesis in the tachyzoite stage but do not eliminate tissue cysts [2].
For ocular toxoplasmosis, topical or systemic corticosteroids may be added to control inflammation, but only after antiprotozoal therapy has been initiated to prevent exacerbation of infection [2].
Treatment in Pregnant Women
Treatment of primary T. gondii infection in pregnant women is aimed at preventing vertical transmission and reducing fetal damage. Spiramycin, a macrolide antibiotic, is used in the first and early second trimester to reduce the risk of transmission [2]. If fetal infection is confirmed, a combination of pyrimethamine and sulfadiazine, with folinic acid supplementation, is used to treat the infected fetus [2]. These treatment protocols are associated with reduced severity of congenital toxoplasmosis but do not eliminate all sequelae.
Prevention Strategies
Prevention of zoonotic transmission of T. gondii from cats to humans, particularly to pregnant women, relies on a combination of environmental hygiene, behavioral modifications, and education.
Litter Box Hygiene
Pregnant women who are seronegative for T. gondii should avoid cleaning the cat litter box if possible [4, 2]. If no alternative exists, the litter box should be cleaned daily, as oocysts require 1 to 5 days to sporulate and become infectious [2]. The use of gloves and a mask during cleaning, followed by thorough hand washing, is recommended [4, 2]. The litter box should be disinfected with boiling water or a 10% ammonia solution to inactivate oocysts.
Cat Management
Keeping cats indoors reduces their exposure to infected intermediate hosts such as rodents and birds [2]. Feeding cats only commercially processed, cooked, or canned food eliminates the risk of ingestion of tissue cysts from raw meat [2]. Cats should not be allowed to roam freely or hunt.
General Hygiene
Pregnant women should practice rigorous hand hygiene after handling raw meat, gardening, or any contact with soil or sand [3, 4, 6, 2, 7]. Fruits and vegetables should be thoroughly washed before consumption. Meat should be cooked to an internal temperature of at least 67 degrees Celsius to kill tissue cysts [2]. Gloves should be worn during gardening.
Education and Screening
Health education programs targeting pregnant women and women of childbearing age are essential for improving knowledge and practices related to toxoplasmosis prevention [3, 4, 6, 2, 7]. Serological screening for T. gondii antibodies in early pregnancy allows identification of seronegative women who require targeted preventive counseling [6, 2, 7].
Decision Tree for Management of Toxoplasmosis Risk in Pregnant Cat Owners
The following Mermaid diagram outlines a clinical decision pathway for veterinary and public health professionals managing the risk of toxoplasmosis in households with pregnant women and cats.
flowchart TD
A[Pregnant woman with cat], > B{Serological screening for T. gondii}
B, >|IgG positive, IgM negative| C[Immune. No special precautions needed beyond general hygiene.]
B, >|IgG negative, IgM negative| D[Seronegative. High risk for primary infection.]
D, > E{Can litter box duty be delegated?}
E, >|Yes| F[Delegate to another household member.]
E, >|No| G[Use gloves and mask. Clean litter box daily.]
D, > H{Cat lifestyle assessment}
H, >|Indoor only, commercial diet| I[Low risk cat. Maintain current management.]
H, >|Outdoor access or raw diet| J[High risk cat. Convert to indoor only and commercial diet.]
D, > K[Provide client education on hygiene, food safety, and gardening precautions.]
K, > L[Schedule follow-up serology in second trimester if clinically indicated.]
Conclusion
Toxoplasmosis in cats represents a significant zoonotic concern, particularly for pregnant women who are seronegative for T. gondii. The cat toxoplasmosis baby transmission pathway is mediated by the ingestion of sporulated oocysts shed in feline feces. Veterinary professionals play a critical role in educating cat owners about the biology of the parasite, the transient nature of oocyst shedding, and the effective preventive measures that can virtually eliminate the risk of transmission. Through a combination of serological screening, environmental hygiene, dietary management, and client education, the risk of congenital toxoplasmosis can be substantially reduced. Continued research into the epidemiology, diagnostics, and treatment of T. gondii infection in both feline and human populations remains essential for public health.
References
[1] Karacali B, Mor N. Investigation of anti-Toxoplasma gondii antibody seropositivity and possible risk factors in women with abortion or stillbirth history in Kars, Turkey. Afr J Reprod Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42202767/
[2] Walana W, Odai SA, Tamomh AG. Prevalence, risk factors, diagnosis and outcomes of Toxoplasma gondii infection in pregnancy: A review. Parasitol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40818495/
[3] Henriette BA, Jémima EK, Jean-Sébastien MA, et al. First report of knowledge and practices towards toxoplasmosis among pregnant women in primary care in Abidjan, Côte d'Ivoire. Trop Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42199683/
[4] Gharbi M, Yera H, Dupouy-Camet J. [The cat, the women and the toxoplasma: What advice should be given to a pregnant woman who is seronegative for toxoplasmosis and owns a cat?]. Gynecol Obstet Fertil Senol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41628830/
[5] Minani S, Di Bari C, Devleesschauwer B, et al. Assessing the burden of congenital toxoplasmosis in Burundi, 2020. Acta Trop. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40915592/
[6] Tahita MC, Kaboré B, Ilboudo H, et al. Toxoplasma gondii seroprevalence and associated factors among pregnant women attending their first antennal care visit in rural Burkina Faso. J Parasit Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40901422/
[7] Benkacem R, Titaouine M, Mammeri A, et al. Cross sectional survey on the prevalence and associated risk factors of toxoplasma infection in pregnant women in Biskra (Southeastern Algeria). Comp Immunol Microbiol Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40683114/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.